Summary
- Current Price
- As of today, IPHA price is $1.40, down -2.10% on
- Current Price All-Time High
- IPHA price is currently -88.28% below its historical high of $11.95 set on
- Market Cap
- IPHA current market cap is $131M, down -36.34% year-over-year
- PE Ratio
- IPHA PE ratio is unknown
- Revenue
- IPHA current annual revenue is $3.15M, down -76.96% year-over-year
- Next Earnings
- The next earnings release for IPHA is on
Profile
| Metric | Value |
|---|---|
| Full Name | Innate Pharma S.A. |
| Ticker | NASDAQ: IPHA |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | France |
| IPO | |
| Indexes | Not included |
| Website | innate-pharma.com |
| Employees | 181 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $1.40 | ||
| Price, 1D Change | -2.10% | |
| $131M | ||
| - | ||
| - | ||
| 0.84 | ||
| $3M | ||
| Revenue, 1Y Change | -76.96% | |
| -$0.62 | ||
| EPS, 1Y Change | +6.16% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.62 | ||
| EPS Estimate | N/A | -$0.55 |
| EPS Est. Change | N/A | +11.70% |
| $3.15M | ||
| Revenue Estimate | N/A | $31.13M |
| Revenue Est. Change | N/A | +889.77% |
| $1.40 | ||
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | -$0.66 | - | |
| -$0.64 | -$0.62 | +3.70% | |
| -$0.55 | N/A | +11.70% | |
| -$0.63 | N/A | -1.69% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $54.96M | $13.65M | -75.16% | |
| $13.23M | $3.15M | -76.23% | |
| $31.13M | N/A | +889.77% | |
| $64.77M | N/A | +1,959.10% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -37.47% | ||
| -53.33% | ||
| -36.34% | ||
| -45.56% | ||
| -76.96% | ||
| -93.96% | ||
| +6.16% | ||
| +19.21% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| $1.40 | ||
| $1.82 | ||
| SMA 200 vs Price | +29.77% | |
| $1.47 | ||
| SMA 50 vs Price | +4.78% | |
| 0.84 | ||
| $0.10 | ||
| 45.43 | ||
| 51.45% | ||
| 62.40% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $3.15M | ||
| -$0.62 | ||
| $0.00 | ||
| 0.00% | ||
| -$67.97M | ||
| -2,161.03% | ||
| -$55.50M | ||
| -1,764.54% | ||
| -$66.41M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| -1.04 | ||
| 1.27 | ||
| 1.27 | ||
| - | ||
| - | ||
| -11.74 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 14.29 | ||
| - | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$25.49M | ||
| $40.30M | ||
| $73.66M | ||
| $54.86M | ||
| $99.15M | ||
| $43.04M | ||
| $26.51M | ||
| $10.34M | ||
| $17.67M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $58.65M | ||
| $67.97M | ||
| - | ||
| $0.00 | ||
| $1.56M | ||
| $0.00 | ||
| -$7.00M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$59.54M | ||
| $8.23M | ||
| $6.85M | ||
| $158.00K | ||
| -$59.70M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| BTIG | → | |
| Leerink Partners | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with IPHA
FAQ
What is the ticker symbol for Innate Pharma S.A.?
The ticker symbol for Innate Pharma S.A. is NASDAQ:IPHA
Does Innate Pharma S.A. pay dividends?
No, Innate Pharma S.A. does not pay dividends
What sector is Innate Pharma S.A. in?
Innate Pharma S.A. is in the Healthcare sector
What industry is Innate Pharma S.A. in?
Innate Pharma S.A. is in the Biotechnology industry
What country is Innate Pharma S.A. based in?
Innate Pharma S.A. is headquartered in France
When did Innate Pharma S.A. go public?
Innate Pharma S.A. initial public offering (IPO) was on October 17, 2019
Is Innate Pharma S.A. in the S&P 500?
No, Innate Pharma S.A. is not included in the S&P 500 index
Is Innate Pharma S.A. in the NASDAQ 100?
No, Innate Pharma S.A. is not included in the NASDAQ 100 index
Is Innate Pharma S.A. in the Dow Jones?
No, Innate Pharma S.A. is not included in the Dow Jones index
When was Innate Pharma S.A. last earnings report?
Innate Pharma S.A.'s most recent earnings report was on November 13, 2025
When does Innate Pharma S.A. report earnings?
The next expected earnings date for Innate Pharma S.A. is May 13, 2026
Data Sources & References
- IPHA Official Website www.innate-pharma.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1598599/000159859925000042/0001598599-25-000042-index.htm
- IPHA Profile on Yahoo Finance finance.yahoo.com/quote/IPHA
- IPHA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ipha